MA SONGJIANG (President) sold 0.1% of their position (2.56K shares) of GYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $26.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/29/2025ACC: 0001140361-25-020754
DirectorOfficer· President
Since Oct 2023
-2.56K
Net shares
Net seller
$26.2K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2.56K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−2K
Price / share
$10.28
Trade value
$20.56K
% of position
0.1%
5/27/2025
2.81M→2.81M
Common Stock
Indirect
Shares
−558.00
Price / share
$10.07
Trade value
$5.62K
% of position
0.0%
5/28/2025
2.81M→2.81M
Total
Net shares
−2.56K
Net value
-$26.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/27/2025 | S · Sale | −2K | $10.28 | $20.56K | 0.1% | 2.81M | 2.81M |
| Common Stock Indirect | 5/28/2025 | S · Sale | −558.00 | $10.07 | $5.62K | 0.0% | 2.81M | 2.81M |
| Total | −2.56K | -$26.18K | ||||||
Derivative Transactions0
No derivative transactions reported